Dr. Johnston is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
26 Hanson Street
Unit #1
Boston, MA 02118Phone+1 617-621-8348
Education & Training
Duke University School of MedicineClass of 1977
Clinical Trials
- Phase 2 Study of MD-1100 Acetate Administered for 14 Days to Patients Meeting Criteria for Chronic Constipation Start of enrollment: 2006 Mar 01
- Trial of Linaclotide in Patients With Chronic Constipation Start of enrollment: 2008 Aug 01
- An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation Start of enrollment: 2008 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 11 citationsSafety and tolerability of linaclotide for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation: pooled Phase 3 analysis.Judy Nee, Jeffrey M. Johnston, Elizabeth P. Shea, Courtney E. Walls, Kenneth Tripp
Expert Review of Gastroenterology & Hepatology. 2019-02-18 - 23 citationsHigh-dose linaclotide is effective and safe in patients with chronic constipation: A phase III randomized, double-blind, placebo-controlled study with a long-term open...Shin Fukudo, Hiroto Miwa, Atsushi Nakajima, Yoshikazu Kinoshita, Masanori Kosako
Neurogastroenterology and Motility. 2019-01-01 - 18 citationsA randomized controlled and long-term linaclotide study of irritable bowel syndrome with constipation patients in JapanShin Fukudo, Hiroto Miwa, Atsushi Nakajima, Ken Haruma, Masanori Kosako
Neurogastroenterology and Motility. 2018-12-01
Press Mentions
Ra Pharmaceuticals Strengthens Senior Management TeamMarch 1st, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
